Humana (HUM) Stock Price

Humana Price

NYSE·CLOSED
386.48USD-21.30 (-5.36 %)
Market closed

Over the last 19 years Humana grew revenue by 9.9% annually, reaching 129.66 B USD. Earnings per share have grown at 6.6% per year over the last 19 years. For Humana, the net margin of 0.9% is down versus 3.5% a few years ago. At today's price the dividend yield works out to roughly 0.92%. The payout ratio is around 36% of earnings. The dividend has grown at 11.7% per year over the past 14 years. The consensus 12-month price target for Humana is 204.00 USD, about 47.2% below where the stock trades today. Of 33 analysts, 10 rate the stock a buy — an overall Hold consensus. The stock trades about 136% above its 52-week low.

Humana stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Humana over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humana stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humana's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Humana Stock Price History
DateHumana Price
7/16/2026386.48 USD
7/15/2026407.78 USD
7/14/2026406.77 USD
7/13/2026407.42 USD
7/10/2026392.22 USD
7/9/2026397.76 USD
7/8/2026398.37 USD
7/7/2026394.62 USD
7/6/2026388.18 USD
7/2/2026396.75 USD
7/1/2026409.42 USD
6/30/2026397.22 USD
6/29/2026382.49 USD
6/26/2026383.84 USD
6/25/2026376.00 USD
6/24/2026361.64 USD
6/23/2026359.13 USD
6/22/2026360.14 USD
6/18/2026367.84 USD
6/17/2026365.98 USD
6/16/2026376.89 USD
6/15/2026371.10 USD
6/12/2026373.98 USD
6/11/2026371.27 USD
6/10/2026366.99 USD
6/9/2026363.18 USD
6/8/2026355.98 USD
6/5/2026346.12 USD
6/4/2026349.68 USD
6/3/2026326.73 USD
6/2/2026325.64 USD
6/1/2026328.91 USD
5/29/2026306.27 USD
5/28/2026307.73 USD
5/27/2026304.60 USD
5/26/2026301.98 USD
5/22/2026308.41 USD
5/21/2026304.89 USD
5/20/2026306.75 USD
5/19/2026310.55 USD
5/18/2026306.00 USD
5/15/2026305.12 USD
5/14/2026301.35 USD
5/13/2026304.85 USD
5/12/2026295.35 USD
5/11/2026274.26 USD
5/8/2026274.96 USD
5/7/2026247.12 USD
5/6/2026246.33 USD
5/5/2026239.53 USD
5/4/2026237.96 USD
5/1/2026233.63 USD
4/30/2026236.44 USD
4/29/2026243.12 USD
4/28/2026229.72 USD
4/27/2026223.62 USD
4/24/2026215.23 USD
4/23/2026214.95 USD
4/22/2026217.40 USD
4/21/2026217.36 USD
4/20/2026210.34 USD
4/17/2026205.14 USD
4/16/2026200.76 USD
4/15/2026198.37 USD
4/14/2026196.21 USD
4/13/2026198.23 USD
4/10/2026192.15 USD
4/9/2026197.32 USD
4/8/2026198.39 USD
4/7/2026197.15 USD
4/6/2026182.65 USD
4/2/2026177.83 USD
4/1/2026176.95 USD
3/31/2026173.39 USD
3/30/2026166.00 USD
3/27/2026169.09 USD
3/26/2026175.14 USD
3/25/2026174.24 USD
3/24/2026172.23 USD
3/23/2026170.14 USD
3/20/2026169.90 USD
3/19/2026166.45 USD
3/18/2026170.42 USD
3/17/2026170.77 USD
3/16/2026169.99 USD
3/13/2026165.43 USD
3/12/2026163.67 USD
3/11/2026170.95 USD
3/10/2026173.62 USD
3/9/2026178.53 USD
3/6/2026179.15 USD
3/5/2026180.75 USD
3/4/2026183.11 USD
3/3/2026181.58 USD
3/2/2026187.28 USD
2/27/2026190.54 USD
2/26/2026186.83 USD
2/25/2026176.06 USD
2/24/2026174.64 USD
2/23/2026181.16 USD
2/20/2026189.83 USD
2/19/2026190.50 USD
2/18/2026187.12 USD
2/17/2026184.99 USD
2/13/2026184.10 USD
2/12/2026178.83 USD
2/11/2026175.40 USD
2/10/2026181.30 USD
2/9/2026189.49 USD
2/6/2026193.94 USD
2/5/2026193.55 USD
2/4/2026192.07 USD
2/3/2026193.02 USD
2/2/2026187.20 USD
1/30/2026195.20 USD
1/29/2026196.67 USD
1/28/2026194.01 USD
1/27/2026207.93 USD
1/26/2026263.63 USD
1/23/2026266.50 USD
1/22/2026266.29 USD
1/21/2026270.67 USD
1/20/2026268.00 USD
1/16/2026273.28 USD
1/15/2026283.95 USD
1/14/2026274.14 USD
1/13/2026273.96 USD
1/12/2026276.59 USD
1/9/2026276.85 USD
1/8/2026277.57 USD
1/7/2026275.06 USD
1/6/2026279.84 USD
1/5/2026275.80 USD
1/2/2026264.48 USD
12/31/2025256.13 USD
12/30/2025259.05 USD
12/29/2025258.34 USD
12/26/2025258.83 USD
12/24/2025259.25 USD
12/23/2025257.12 USD
12/22/2025257.68 USD
12/19/2025259.40 USD
12/18/2025260.67 USD
12/17/2025260.28 USD
12/16/2025258.16 USD
12/15/2025274.74 USD
12/12/2025268.45 USD
12/11/2025266.49 USD
12/10/2025256.66 USD
12/9/2025250.39 USD
12/8/2025256.39 USD
12/5/2025257.85 USD
12/4/2025253.02 USD
12/3/2025256.92 USD
12/2/2025241.96 USD
12/1/2025242.23 USD
11/28/2025245.77 USD
11/26/2025245.99 USD
11/25/2025237.88 USD
11/24/2025229.20 USD
11/21/2025227.10 USD
11/20/2025223.29 USD
11/19/2025228.90 USD
11/18/2025234.10 USD
11/17/2025234.11 USD
11/14/2025237.12 USD
11/13/2025236.74 USD
11/12/2025240.48 USD
11/11/2025243.47 USD
11/10/2025238.42 USD
11/7/2025252.04 USD
11/6/2025251.11 USD
11/5/2025264.94 USD
11/4/2025281.87 USD
11/3/2025279.92 USD
10/31/2025278.19 USD
10/30/2025285.61 USD
10/29/2025292.67 USD
10/28/2025294.80 USD
10/27/2025292.34 USD
10/24/2025290.65 USD
10/23/2025291.30 USD
10/22/2025287.72 USD
10/21/2025295.20 USD
10/20/2025284.00 USD
10/17/2025275.01 USD
10/16/2025267.28 USD
10/15/2025262.17 USD
10/14/2025261.61 USD
10/13/2025271.00 USD
10/10/2025280.22 USD
10/9/2025290.60 USD
10/8/2025298.04 USD
10/7/2025295.25 USD
10/6/2025295.20 USD
10/3/2025283.72 USD
10/2/2025256.62 USD
10/1/2025246.77 USD
9/30/2025260.17 USD
9/29/2025255.23 USD
9/26/2025254.95 USD
9/25/2025254.43 USD
9/24/2025261.97 USD
9/23/2025258.32 USD
9/22/2025257.87 USD
9/19/2025252.66 USD
9/18/2025264.86 USD
9/17/2025269.39 USD
9/16/2025272.32 USD
9/15/2025275.42 USD
9/12/2025276.44 USD
9/11/2025278.72 USD
9/10/2025273.58 USD
9/9/2025273.02 USD
9/8/2025310.38 USD
9/5/2025307.92 USD
9/4/2025312.00 USD
9/3/2025311.98 USD
9/2/2025310.06 USD
8/29/2025303.66 USD
8/28/2025297.89 USD
8/27/2025297.26 USD
8/26/2025298.87 USD
8/25/2025297.20 USD
8/22/2025299.51 USD
8/21/2025294.47 USD
8/20/2025290.00 USD
8/19/2025288.25 USD
8/18/2025287.19 USD
8/15/2025286.39 USD
8/14/2025281.34 USD
8/13/2025281.99 USD
8/12/2025274.94 USD
8/11/2025266.67 USD
8/8/2025266.68 USD
8/7/2025256.14 USD
8/6/2025256.62 USD
8/5/2025254.47 USD
8/4/2025247.35 USD
8/1/2025247.26 USD
7/31/2025249.87 USD
7/30/2025261.47 USD
7/29/2025232.62 USD
7/28/2025231.52 USD
7/25/2025237.98 USD
7/24/2025229.21 USD
7/23/2025237.12 USD
7/22/2025231.12 USD
7/21/2025223.43 USD
Access this data via the Eulerpool API

Humana Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
106.37 B USD
4.67 B USD
2.49 B USD
Jan 1, 2024
117.76 B USD
3.04 B USD
1.21 B USD
Jan 1, 2025
129.66 B USD
3.41 B USD
1.19 B USD
Jan 1, 2026 (e)
162.52 B USD
2.18 B USD
1.11 B USD
Jan 1, 2027 (e)
172.44 B USD
3.04 B USD
1.85 B USD
Jan 1, 2028 (e)
185.46 B USD
4.68 B USD
3.08 B USD
Jan 1, 2029 (e)
201.04 B USD
6.20 B USD
4.50 B USD
Jan 1, 2030 (e)
215.15 B USD
5.96 B USD
4.13 B USD

Humana Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 18, 2026, 5:22 PM
 
REVENUEB USD
REVENUE GROWTH%
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
54.3853.7756.9164.8977.1683.0692.87106.37117.76129.66162.52172.44185.46201.04215.15242.82
0.17-1.135.8514.0118.907.6611.8114.5410.7010.1125.346.117.558.407.0212.86
1.743.333.103.194.993.284.154.673.043.412.183.044.686.205.96
3.206.195.454.926.463.944.474.392.582.631.341.772.523.092.77
0.612.451.682.713.372.932.812.491.211.191.111.853.084.504.134.29
-51.88298.70-31.2560.8424.38-12.89-4.33-11.30-51.51-1.57-6.4866.2566.7646.17-8.243.82
0.871.892.002.202.502.803.153.543.543.543.543.804.07
-24.35117.245.8210.0013.6412.0012.5012.387.347.11
151.00146.00138.00135.00133.00129.00127.00124.44120.87120.83120.83120.83120.83120.83120.83120.83
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Humana generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humana retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humana's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Humana has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humana's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Humana stock margins

The Humana margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Humana. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Humana.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
0.00 %
3.94 %
3.53 %
Jan 1, 2022
0.00 %
4.47 %
3.02 %
Jan 1, 2023
0.00 %
4.39 %
2.34 %
Jan 1, 2024
0.00 %
2.58 %
1.02 %
Jan 1, 2025
0.00 %
2.63 %
0.92 %
Jan 1, 2026 (e)
0.00 %
1.34 %
0.68 %
Jan 1, 2027 (e)
0.00 %
1.77 %
1.07 %
Jan 1, 2028 (e)
0.00 %
2.52 %
1.66 %

Humana Stock Revenue, EBIT, Earnings per Share

The Humana earnings per share therefore indicates how much revenue Humana has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
643.91 USD
25.40 USD
22.74 USD
Jan 1, 2022
731.26 USD
32.70 USD
22.09 USD
Jan 1, 2023
854.81 USD
37.50 USD
20.00 USD
Jan 1, 2024
974.29 USD
25.18 USD
9.99 USD
Jan 1, 2025
1,073.15 USD
28.19 USD
9.83 USD
Jan 1, 2026 (e)
1,353.74 USD
18.00 USD
9.26 USD
Jan 1, 2027 (e)
1,436.41 USD
25.19 USD
15.39 USD
Jan 1, 2028 (e)
1,544.83 USD
38.71 USD
25.66 USD

Humana business model & stock analysis

Humana Inc. is an American company that specializes in health and social services. It was founded in 1961 in Louisville, Kentucky by David Jones and Wendell Cherry to acquire and operate hospital chains. Today, Humana offers a wide range of health and social services for customers of all ages. The business model of Humana is based on providing health and social services to private, government, and commercial customers. The company aims to improve the health and well-being of people by providing them access to high-quality and affordable services in healthcare, life and disability insurance, and care. Humana's various divisions are tailored to the needs of customers. The Humana Health division includes offerings such as health insurance, medical care, and prevention programs to avoid illnesses. The Humana Dental division provides comprehensive dental care to customers, including preventive exams, routine treatments, and repairs. Therapy and medical devices are also included in Humana's offerings. The company has also focused on senior care. In recent years, Humana has made several acquisitions of companies that offer care services for seniors. This allows them to provide customers with a comprehensive range of physical and mental care services. Building nursing homes and financing hospices are also part of Humana's offerings. In addition to the mentioned services, Humana also offers health promotion and prevention programs, such as sports programs and mental health training for individuals with depression or anxiety disorders. Humana is a globally operating company based in Louisville, Kentucky and serves customers in the USA and internationally. The company employs over 41,000 employees and has an annual revenue of approximately $56.9 billion. Overall, Humana is a company that focuses on improving the health and well-being of customers worldwide. It offers a wide range of health and social services for people of all ages and from all walks of life. The commitment to senior care allows Humana to focus on a sustainable future for its customers, while the offering of prevention programs ensures the preservation of a healthy society and economy.

Humana SWOT Analysis

Strengths

Humana Inc. has established a strong market position in the healthcare industry, particularly in the health insurance sector. This strong presence gives the company a competitive advantage and enhances its brand value.

Humana offers a diverse range of health insurance products and services, including individual and group coverage plans, Medicare, and Medicaid plans. This diverse product portfolio allows the company to cater to a wide range of customer needs.

Weaknesses

A significant portion of Humana's revenue comes from government-sponsored healthcare programs such as Medicare and Medicaid. The company's heavy reliance on these programs exposes it to changes in government regulations and policies, which can impact its financial performance.

Humana's operations are mainly focused in the United States. While this allows the company to have a deep understanding of the local market, it also limits its growth potential in international markets. Expanding into new geographic regions could be a challenge for the company.

Opportunities

The increasing aging population creates a significant opportunity for Humana. With its expertise in Medicare and other senior-focused healthcare plans, the company can benefit from the growing demand for healthcare services among the elderly population.

Rapid advancements in technology present opportunities for Humana to improve its healthcare delivery systems, enhance customer experience, and streamline its operations. Embracing technologies like telemedicine and digital health solutions can give the company a competitive edge.

Threats

The healthcare industry is highly competitive, with multiple players vying for market share. Humana faces competition from other health insurers, as well as from hospitals, healthcare providers, and new entrants to the market. This competitive landscape poses a threat to the company's growth and profitability.

The healthcare industry is heavily regulated, and changes in government regulations and policies can significantly impact Humana's operations and profitability. Moreover, political uncertainty and debates surrounding healthcare reform can create challenges and uncertainties for the company's future.

Humana Segments

Humana Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
External Revenues
Jan 1, 2022
0.00 USD

Humana Revenue by Segment (2/2)

  • 3 Years

  • Max

Insurance
CenterWell
Details
Date
Insurance
CenterWell
Jan 1, 2022
88.84 B USD
17.31 B USD

Humana Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Humana historical P/E ratio, EBIT multiple, and P/S ratio

Humana annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Humana shares outstanding

The number of shares of Humana was 120.83 M in 2025. This indicates how many shares Humana is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
129.00 M Stocks
Jan 1, 2022
127.00 M Stocks
Jan 1, 2023
124.44 M Stocks
Jan 1, 2024
120.87 M Stocks
Jan 1, 2025
120.83 M Stocks
Jan 1, 2026 (e)
120.83 M Stocks
Jan 1, 2027 (e)
120.83 M Stocks
Jan 1, 2028 (e)
120.83 M Stocks

Humana stock splits

In Humana's history, there have been no stock splits.

Humana Dividend History

20 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.89USDYTD
Mar 27, 20260.89USD 0.0%1/1
20253.54USD 0.0%
Mar 28, 20250.89USD 0.0%1/4
Jun 27, 20250.89USD 0.0%2/4
Sep 26, 20250.89USD 0.0%3/4
Dec 26, 20250.89USD 0.0%4/4
20243.54USD 0.0%
20233.54USD 12.4%
20223.15USD 12.5%
20212.80USD 12.0%
20202.50USD 13.6%
20192.20USD 10.0%
20182.00USD 5.8%
20171.89USD 117.2%

Humana dividend history and estimates

In 2025, Humana paid a dividend amounting to 3.54 USD. Dividend means that Humana distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
2.80 USD
0.00 USD
Jan 1, 2022
3.15 USD
0.00 USD
Jan 1, 2023
3.54 USD
0.00 USD
Jan 1, 2024
3.54 USD
0.00 USD
Jan 1, 2025
3.54 USD
0.00 USD
Jan 1, 2026 (e)
0.89 USD
2.66 USD
Jan 1, 2027 (e)
0.00 USD
3.80 USD
Jan 1, 2028 (e)
0.00 USD
4.07 USD

Humana dividend payout ratio

In 2025, Humana had a payout ratio of 36.00%. The payout ratio indicates the percentage of the company's profits that Humana distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
12.32 %
Jan 1, 2022
14.27 %
Jan 1, 2023
17.70 %
Jan 1, 2024
35.45 %
Jan 1, 2025
36.00 %
Jan 1, 2026 (e)
38.24 %
Jan 1, 2027 (e)
24.65 %
Jan 1, 2028 (e)
15.85 %

Current Humana forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
2.91 %
Buy30.30 % (10)
Hold63.64 % (21)
Sell6.06 % (2)
12M Price Target
204.00
Last Price
400.00
Currency
USD
12M Return Potential
-49.00 %
LTM Return
0 %

Humana Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/29/20267.27USD41.02 BUSD2026 Q2
4/29/202610.13USD39.76 BUSD2026 Q1
2/11/2026-4.05USD32.40 BUSD2025 Q4
4/24/202410.38USD28.86 BUSD2024 Q1
1/30/20242.20USD25.79 BUSD2023 Q4
7/25/20238.99USD25.88 BUSD2023 Q2
4/25/20238.75USD26.18 BUSD2023 Q1
1/31/20231.49USD22.82 BUSD2022 Q4
11/2/20226.35USD23.10 BUSD2022 Q3
7/27/20227.75USD23.82 BUSD2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Humana stock

65/100
69
Environment
61
Social
64
Governance
E

Environment

20
Scope 1 - Direct Emissions37,480
Scope 2 - Indirect emissions from purchased energy62,892
Scope 3 - Indirect emissions within the value chain14,366,771
Total CO₂ emissions100,372
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees75
Percentage of women in management
Percentage of Asian employees6.06
Share of Asian management
Percentage of Hispanic/Latino employees16.18
Hispano/Latino Management share
Percentage of Black employees17.44
Black Management Share
Percentage of white employees56.87
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Humana shareholder structure

% Name
11.83096%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
9.40478%
Dodge & Cox
Dodge & Cox
5.42290%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
4.84632%
Capital International Investors
Capital International Investors
4.55023%
State Street Investment Management (US)
State Street Investment Management (US)
3.69159%
MFS Investment Management
MFS Investment Management
...

Humana Executives and Management Board

DD

Mr. David Dintenfass

(54)

President - Enterprise Growth

Compensation18.06 M USD
JR

Mr. James Rechtin

(54)

President, Chief Executive Officer, Director · since 2024

Compensation15.58 M USD
SS

Dr. Sanjay Shetty

(51)

President - CenterWell

Compensation6.44 M USD
GR

Mr. George Renaudin

(56)

President - Insurance

Compensation6.15 M USD
JV

Mr. Joseph Ventura

(47)

Chief Legal Officer

Compensation3.10 M USD

Humana Supply Chain

Humana Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
30 companies
#Name1M3M6M1Y2YTrend
1
Tivity Health
Supplier
0.42
0.40
0.41
0.41
0.46
2
0.06
0.12
0.17
0.13
0.44
3
0.64
0.58
0.71
0.25
0.42
4
0.23
0.26
0.61
0.18
0.41
5
0.17
0.13
-0.32
-0.13
0.39
#Name1M3M6M1Y2YTrend
1
Signify Health A
Supplier
0.67
0.29
0.44
0.07
2
-0.27
-0.30
0.30
3
Confluent A
Supplier
0.48
0.38
-0.16
4
GoHealth A
Supplier
0.36
-0.04
-0.08
0.12
5
0.21
-0.14
0.09
-0.05

Frequently asked questions about Humana

The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.

All fundamentals and in-depth analysis of Humana

Our stock analysis for Humana stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.